ADO and metabolic disease: However, while the variations in these factors for amino acids, acylcarnitines, and other traditional screening biomarkers have been thoroughly investigated, relatively few studies have specifically focused on the newly incorporated ADO marker, which is part of the NeoBase2 kit used for detecting metabolic disorders.